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INTRODUCTION
Perinatal asphyxia refers to a lack of oxygen severe enough to
cause metabolic acidosis, increased lactate levels and delay the onset of
respiration in a neonate.
The classic way of defining a perinatal asphyxia is with low apgar
score, low arterial blood pH and increased base deficit.
Criteria for significant asphyxia include
a) Signs of fetal distress as indicated by one or more of the following:
? Fetal bradycardia (? 100 beats/min)
? Thick meconium staining of liquor
? Abnormal cardiotocography recordings.
? Arterial cord pH < 7.2 or base deficit > 15mmol/L
b) Apgar score < 6 at five minutes of life.
c) Need for > 1 minute of positive pressure ventilation before occurrence
of sustained respiration[12]
ETIOPATHOGENESIS OF HYPOXIC ISCHAEMIC
ENCEPHALOPATHY
Reduced oxygen supply to brain causes hypoxic ischaemic
encephalopathy to the brain. This can occur if there is  reduced amount of
oxygen in the blood (hypoxia) or a reduced supply of blood to the brain
(ischemia).
Hypoxia or ischemia, either alone or both together can occur
during the perinatal period as perinatal asphyxia leading to the subsequent
brain injury or damage.
During the course of normal labour and child birth many babies are
born with decreased oxygen reserve. This mild depletion of oxygen
occurs because of many physiological alterations during the childbirth.
They are
1. Intermittent uterine contractions, cord compressions, maternal
dehydration and maternal alkalosis due to hyperventilation.
2. Reduced placental blood flow causing reduction in oxygen supply
to fetus
3. Physiological stress causing increased oxygen uptake by both
mother and fetus
This little amount of hypoxia is usually well compensated by the
newborn. But if this physiological stress is added to asphyxia it causes
many intracellular and metabolic disturbances causing pathological
hypoxic ischaemic injury.
Hypoxia
Brain damage is assumed to be caused by either hypoxia or
asphyxia.
And babies who go on to HIE are born asphyxiated at birth and
ACOG (18)“strongly supports that a neonate who had hypoxia prior to
delivery severe enough that it causes HIE will also have other abnormal
findings like:
1. Cord arterial blood pH <7
2. Apgar 0-3 at 5 minutes
3. Neurological sequelae and multi organ dysfunction[13]
Human brain doesnot have stored energy
Its metabolic demands are met by constant supply of glucose and
oxygen. In glycolysis each molecule of glucose is broken down to form
38 ATP molecules. hypoxic injury shifts it into anaerobic metabolism. It
is very energy inefficient producing only 2 molecules of ATP. It also
produces lactate. lactate accumulation is detrimental because it causes a
break down of blood brain barrier. It also causes cerebral edema.
Anaerobic metabolism causes accumulation of carbon di oxide which
causes impaired cerebral autoregulation, glycolysis is inhibited and tissue
injury ensues.14
CEREBRAL BLOOD FLOW REDISTRIBUTION – DIVING
REFLEX
During the time of asphyxial insult, various physiological
mechanisms get activated and blood flow to brain is preserved by
redistribution. This causes an increase in blood flow to brain to increase
by 30-175 times. This is caused by decreased cerebrovascular resistence
and production of increased systemic blood pressure. This compensatory
mechanism depends on the speed of onset of asphyxial insult.
 But very severe asphyxia, if rapid in onset results in a decrease in
the blood flow to the brain. This is due to cerebral vasoconstriction.
There is a failure of these physiologic responses during prolonged
periods of asphyxial insult causing reduced cardiac output , and systemic
hypotension with reduced cerebral blood flow.14 the decrease in cerebral
perfusion can be compensated for by rapid dilatation of smaller blood
vessels in the brain usually, As long as systemic blood pressure is kept in
constant level.  The term autoregulation is used for this constancy of
cerebral blood flow despite the changes in systemic blood pressure.
Autoregulation is maintained mainly by larger arteries and less
importantly, arterioles.
Endothelium dependent blood pressure changes play a major role
in this autoregulation.16
Cerebral arterial tone is mediated by many chemicals.Nitric oxide,
causes vascular dilatation by activating the calcium-activated potassium
channel of vascular endothelium. Adenosine also causes
vasodilatation.17,18 endothelin-1 and prostanoids mediate vasoconstriction
. Impairment of cerebral autoregulation can be caused by hypoxia,
hypercarbia, and hypoglycemia.
Due to hypoxic insult autoregulation becomes impaired. It fails to
respond to changes in blood pressure and blood carbon dioxide
concentrations, resulting in a pressure-passive cerebral blood flow.
Pressure passive blood flow means that the cerebral blood flow directly
depends on the systemic vascular resistance.
When the initial insult ends, the vasodilatory factors cause an
increase in the cerebral blood flow.This is followed by a transient decline.
Then a second, delayed increased phase of blood flow happends
due to increased sysnthesis of nitric oxide. Most of the injury to the brain
occurs during this delayed phase.
Mechanisms of brain injury following hypoxic-ischemic event
Hypoxic-ischemic insult produces neuronal death by two major
mechanisms.
1) Primary neuronal cell loss happening at the time of the insult
2) Delayed neuronal cell loss which occurs later.[19]
During the initial insult primary energy failure happens and causes
cellular depolarizaztion.  During this stage 3 mechanisms cause cellular
death.
A) Hypoxia causes neuronal depolarisation. Sodium influx happens
and potassium efflux is decreased along with chloride entry. Due to
this electrochemical change, cellular swelling happens and also
leading to cellular lysis.
B)  Intracellular calcium concentration increases. This happens due to
increased calcium influx and decreased calcium removal by the
defective sodium calcium transporter.
C)  Glutamate accumulates outside the cells(excitatory
neurotransmitter) due to defective uptake and overt release due to
the hypoxic insult.
The increased glutamate causes excess calcium accumulation insde
the celln by activating the NMDA receptors.
Further damage to cell membrane occurs due to the action of free
radicals in the immediate reperfusion phase.20 This secondary loss of
neurons is termed secondary or delayed neuronal death. Neuronal death
during the delayed phase causes irritability and excitotoxic phase lasting
for 4-72 hours.[21]
Inflammatory mechanisms involved in hypoxia-ischemia
A positive corerelation has been found between inflammatory
cytokines and hypoxic ischaemic encephalopathy. Their levels are
significantly increased in hypoxic ischaemic sequelae infants who later
develop cerebral palsy. [22]increased levels of IL-6 correlates well with the
poor neurological outcome in asphyxiated infants.[23]  correlation between
elevated lactic acid level in the basal ganglia and serum IL-1, IL-6, IL-8
and TNF? levels has been found using MR spectroscopy in infants with
HIE. [24] In a study, newborn mice were subjected to unilateral carotid
artery ligation. It showed that there is an increased expression of many
inflammatory genes associated with cellular activation in the injured
hemisphere of the brain.[25]
The gene expressed suggests the microglial activation. It starts to
begin expressed at 8 hours and lasts upto 72 hours. Chemokines and
proinflammatory cytokines also accumulate around the lesion. Post
asphyxia infants show an accumulation of microglia around the dentate
gyrus.
Microglia causes secondary brain damage due to release of
excitotoxic chemicals such as quinolinic acid.
ROLE OF FREE RADICALS AND REACTIVE OXYGEN
SPECIES IN HYPOXIA-ISCHEMIA
Adenosine or hypoxanthine levels increase during repeated
episodes of hypoxia. This causes enhanced cellular damage on
reoxygenation causing reperfusion injuries. (27) oxidases such as
nitrogen oxide synthase (NOS) get activated , hypoxia inducible factor-1
alpha (HIF-1?) levels get increased, as well as decrease in levels of
antioxidant enzymes, such as superoxide dismutases, catalases, and
glutathione peroxidases. These factors cause increase in reactive oxygen
species levels.(28) nNOS immunoreactivityincreses has been documented
in nerve fibers of thalamus for more than a week in hypoxic infants.[29]
Apoptotic mechanisms involved in hypoxia-ischemia
Multiple apoptotic pathways play a role in cellular death in infants
of hypoxia. The post-mortem brain tissue of full term neonates with
severe perinatal asphyxia correlates well with increased levels activated
caspases.[30] Hypoxia–ischemia causes an activation of Fas death receptor
signaling in the neonatal brain.
CLASSIFICATION OF STAGES
Classification helps in assessing the disease prognosis and in
comparing the data for future reference. Hypoxic ischaemic
encephalopathy has been classified by various methods of classification.
In 1976, a classification system was published by sarnat and sarnat.[31]this
study related the electroencephalogram findings to the clinical features of
the infants.
It helps in staging and prognostication of the newborn and is still
widely used system. The hypoxic ischaemic encephalopathy is classified
into 3 stages as mentioned below:
Amiel-Tison  added  MRI,  EEG  and  VEP  with  Sarnat  scoring
system and Miller included the comparison along with feeding difficulties
(31,32) .
Dubowitz added optimality score therby offering a revised system
applicable during the first days of life[34]. The point of Dubowitz's
investigation was to assess the dispersion of different discoveries and
their conceivable variety with gestational age in the scope of term birth
(37-42wks) and to build up an optimality score to help distinguish
irregularities happening in just a little minority of typical newborn
children. Some of the variables used by Dubowitz included posture, arm
recoil, leg traction, popliteal angle, head control-flexor tone, arm traction,
leg recoil, and extensor tone, head lag, and ventral suspension.
Another classification is by Levene, according to which HIE is
typed as
a) Mild (I) showing Hyperalertness, mild hypotonia, normal
/decreased spontaneous motor activity, and poor suck
b) Moderate (II) showing seizures, lethargy, marked tone
abnormality (arms >legs),and requirng tube feeding
c) Severe (III) features include coma, no spontaneous movements,
severe hypotonia , prolonged seizures, and unable to maintain
normal respiration.
Newborns with mild encephalopathy have maximum symptoms
during the first 24 hours and then it wanes off characterisd by increased
Irritability and jitteriness. They have normal EEG pattern, remain seizure
free and have generally good prognosis. Neonates who present with
altered levels of consciousness and clinical/subclinical seizure activity
12-24 hours after the hypoxic-ischemic event would have developed
moderate-severe HIE (II-III). Electrophysiology studies are abnormal in
this group, including seizure activity and abnormal background pattern on
aEEG. Grade III or severe HIE leads to decreased / absent reflex activity,
failure of respiratory activity and coma and obtundation. These most
severe  forms  of  HIE  usually  is  fatal  or  go  on  to  develop  severe
neurological abnormalities. The change in severity should be recognised
at the earliest. It relates well with the prognosis and the stage of HIE. The
Thompson score[35] includes a comprehensive grading of signs of
ischaemic encephalopathy. It includes 9 parameters in the infant which
includes tone, loss of consciousness, grasp, suck, respiration,  seizures,
posture, morosreflex, and the fontanelle. Each of the variable is given a
score from 0 to 3, where a score of 0 is considered as normal for each. At
one  year  of  age,  it  has  a  high  predictive  value:  a  peak  score  of  15  or
higher has a positive predictive value of 92% and a negative predictive
value of 82% for abnormal outcome, with a sensitivity and specificity of
71% and 96%, respectively. This score was used widely because it tells
and predicts the neurological status of the infant in the first few hours
hours of life in contrast to the sarnat and sarnat staging, which is reliable
only after 24 hours. This is a reasonable systemof scoring and is
especially useful in areas where there are not many facilities for
sophisticated investigations.
MECHANISMS OF LIVER INJURY IN PERINATAL HYPOXIA
The prognostic value of the Apgar score for detection of hypoxic
ischemic brain disease is insufficient during the first hour of animation
because it can be decreased during depression from maternal drugs,
anomalous babies, trauma, or metabolic or infectious insults. A
biochemical parameter that correlates with HIE is of interest since
ventilator treatment, sedative drugs, and anticonvulsant therapy could
bring  on  an  evaluation  of  severity  of  HIE  difficult.  Multiple  organ
dysfunction in birth asphyxia is a possible issue of adaptive mechanism.
Thus, if the contrary effects of hypoxia on the newborns are considered,
there is a demand to identify infants who will be at high risk of hypoxic
ischemic brain disease and early neonatal death as a result of perinatal
hypoxia. Different kinds of markers have been studied to identify
perinatal hypoxia, including electronic fetal heart monitoring, cord pH,
electroencephalograms, and Doppler flow studies. Supplementary
methods for diagnosis and prediction of antenatal and non-acidotic
prolonged asphyxia are lacking. Injured cells leak intracellular enzymes
such as LDH, alanine transaminase, and aspartate transaminase. These
enzymes may be utilized as possible predictors of timing and grade of
hypoxic ischemic injury in both perinatal period and in infants with
antepartum asphyxia.
ALT and AST levels increase as a result of hypoxia organ damage
and mainly liver parenchyma, which calls for an equal quantity of
oxygen, glucose, and nutrients for its use. Increased activities of ALT and
AST are sensitive markers of impaired liver membrane, generally in
situations with decreased intake of energetic substrates into the cell. A
statistically significant depression in ALT and AST values of asphyxiated
neonates was found on the third day of life because of stabilization of the
babies and normalization of their liver functions on day 10.[50]
ALT and AST levels on day 1 correlates well with the severity of
HIE, and the poor degree of correlation was noticed with the severity of
asphyxia according to the Apgar score.
ALKALINE PHOSPHATASES
They are a family of zinc metalloenzymes. The mechanism by
which ALP reaches the circulation is uncertain; leakage from the bile
canaliculi into hepatic sinusoids may result from leaky tight junctions.
Consequently, the estimation of alkaline phosphate levels can suggest any
kind of liver abuse. The present work demonstrated that serum ALP
increased more than the command group, and the differences were
statistically significant, but significant correlation with stages of HIE was
not  established.  Islam  et  al.  reported  mean  ALP  similar  to  our  study  in
asphyxiated neonates, but showed significant correlation with stages of
HIE [51].
LACTATE DEHYDROGENASE
A  serial  rise  in  levels  of  LDH  or  failure  to  come  down  in  the
beginning few days of life indicates hepatic impairment. LDH levels
increased in response to asphyxia insult. The level of rise of growth in
levels of LDH depends on hepatic dysfunction.,the mechanism has not
been elucidatedfully, several authors recently reported that over-
activation of macrophages plays a key role in the progression of hypoxic
hepatitis. The activated and proliferating macrophages in the liver could
injure endothelial cells and cause a disturbance in the hepatic
microcirculation.
Meanwhile, LDH is an essential enzyme involved in anaerobic
glycolysis and is responsible for the anaerobic transformation of pyruvate
to lactate.
Increased expression of LDH under hypoxic conditions has been
demonstrated in various cell lines. Concerning liver diseases, it is well
known that dominant elevation of serum LDH is observed in hypoxic
hepatitis caused by shock or heart failure.
Although the elevation of LDH activity in acute liver injury has
been simply supposed to be enzyme leakage through damaged hepatocyte
membranes, as the seen with ALT, increased LDH production could also
be attributable to anaerobic conditions. The hepatocytes are expected to
increase the production of LDH under anaerobic conditions, until they
become necrotic. From this viewpoint, the persistent low ALT-LDH
index in fatal patients might be the result of increased production of LDH
from residual living hepatocytes in hypoxia. Prolonged hypoxic
conditions could cause massive or lobular necrosis, which coincides with
the pathologic findings of ALF. When we accept the mechanism
described above, acute liver injury could be supposed to consist of two
different processes of cell destruction.
1. One is direct cytotoxicitytoward hepatocytes caused by various
triggers. In mosthypoxic hepatitis, cytotoxic T cells
attackhepatocytes directly. In this process, the increased releaseof
enzymes into the serum is the result of simple leakagefrom injured
hepatocytes, and enzyme activities decreaserapidly, according to
their half-lives, as soon as the triggers are removed or inactivated.
2. The other mechanism ishypoxic liver injury caused by disturbance
of the hepatic microcirculation. The persistent low ALT-LDH
index mayimply the situation that the hypoxic process
mainlyremains after the removal of the trigger of liver injury.
3. Most acute liver injury might be explained as a mixture ofthese two
mechanisms, to various degrees.
TOTAL PROTEIN AND SERUM ALBUMIN
Albumin’s numerous functions include maintenance of colloid
osmotic pressure (accounting for 80%), buffering, and transport of
bilirubin, uremic toxins, fatty acids, metals, cortisol, thyroxine,
endotoxins, medications, and endogenous nitric oxide. Furthermore, it is
supposed to be an important antioxidant and as such could play a role in
neuronal survival during development. These functions are of vital
importance to the critically ill newborn baby. Albumin can be measured
cheaply  and  well.  Thus,  estimation  of  total  protein  and  serum  albumin
can indicate hepatic insult. significantly lower values of total protein and
serum albumin in asphyxiated neonates were and that they correlate
poorly with the severity of birth asphyxia as assessed by HIE stage and
Apgar score.[51]. The prevalence ofhypoproteinemiawas 34% in
asphyxiated newborns. The present study showed 20% prevalence
ofhypoproteinemia. Tarcan et al. showed that hypoproteinemia is an
imprecise index of the severity of liver damage in birth asphyxia because
of the long life of serum proteins, and caution was used in interpreting
hypoalbuminemia as this can result from capillary leakage.
furthermorelow protein and albumin may not be applicable to preterm
neonates as they normally have low protein and albumin because of
hepatic immaturity.
TSB AND DSB
Bilirubin is a breakdown product of hemoglobin. The liver is
responsible for clearing of bilirubin. The levels of serum bilirubin is
found to be significantly higher in the asphyxiated neonates compared to
the controls and hence serves as a marker for hepatic dysfunction in
asphyxia. However it is correlated poorly with the degree of asphyxia[53]
PROTHROMBIN TIME AND INR
Clotting is the end effect of a complex series of enzymatic
reactions that require at least 13 genes. The liver is the major site of
synthesis of  11 blood coagulation proteins. Most of them are only
present in excess, and abnormalities of coagulation results when there is
substantial impairment in the ability of the liver to synthesize these
factors; thus, it is a measure of liver dysfunction. Prothrombin time and
INR were significantly higher in asphyxiated neonates; other authors also
noted similar results. Hypoproteinemia, and prolonged prothrombin time
and INR were noted to be the ominous signs predicting mortality in our
study. The limitation of our discipline is our inability to detect subtle
injury to the liver by using sophisticated tests such as immunoflurometric
assay for glutathione S-transferase A (GSTA) and histopathological
alteration by taking a liver biopsy as availability, feasibility, and cost
factor restrict their daily use.[53]
INTERVENTIONS - PREVENTION AND TREATMENT[55]
Interventions to reduce perinatal asphyxia in less
developedcountries may be the most cost effective methods forachieving
further reductions in infant mortality andpreventing future disability. The
provision of goodantenatal care to identify and target those mothers
athighest risk and to treat preventable risk factors, and theprovision of
accessible safe delivery (both geographicallyand economically) are the
highest priorities. The effects ofrecession and economic structural
adjustment programmesin many developing countries over the past
decade havehad precisely the opposite effect. There is clear evidence
forreduced utilisation of antenatal and perinatal services byvulnerable
groups in many communities where user chargeshave been introduced
with reversals in trends formaternal mortality rates and the incidence rates
for low birth weight. Until recently the only option for most mothers in
thedeveloping world was domiciliary delivery. Training oftraditional
birth attendants was considered the mostappropriate policy for improving
safe delivery andreducing asphyxia in the community. But evaluation
oftraining programmes for traditional birth attendants hasshown they
work best when supported closely by a referralfacility. In urban areas (of
Asia especially) there has been asharp increase in demand for institutional
delivery,although the quality of service is often poor and rarely audited.
Resuscitation plays a significant part in safe delivery. The cost
effectiveness of training programmes in resuscitationfor traditional birth
attendants is still in question eventhough evaluation of such training has
shown that theirknowledge and practices related to resuscitation
maychange in the short term.
Prevention is not the only priority. Many asphyxiatedbabies might
profit from appropriate and timely treatment.While trials of some
potentially low costtreatments such as lidocaine,naloxone,thiopentone,
and paraldehyde, have been of doubtful benefit there isreason to hope that
new trials using free radical scavengers(vitamin E), nitric oxide blockers,
excitatory amino acidantagonists (for example magnesium ions which
blockglutamate receptorsor calcium channel blockers could reveal
potentially cost effective interventions.
NEED OF THE STUDY
Birth Asphyxia is the commonest primary cause of neonatal death
(54.9%). In India, 8.4% of inborn babies have a 1 minute Apgar score
less than 7 and 1.4% suffer from hypoxic ischemic encephalopathy
(HIE).1
Apgar scoring is used as a predictor of survival in asphyxiated
neonates, but it can also be decreased in depression from maternal drugs,
anomalous babies, trauma, metabolic or infectious insults. The predictive
value of Apgar score for detection of hypoxic ischemic encephalopathy is
insufficient during first hour of life.2 A biochemical parameter that
correlates with hypoxic ischemic encephalopathy is of interest since
ventilator treatment, sedative drugs and anticonvulsant therapy could
make evaluation of severity of hypoxic ischemic encephalopathy
difficult.
The defense mechanisms when a fetus is exposed to hypoxia-
ischemia is based on ability to centralize cardiac output to prioritized
organs  such  as  the  brain,  heart  and   the  adrenals  at  the  expense  of  less
important organs such as the liver, lungs, skin and muscles. Multi organ
dysfunction is a natural consequence of this defense mechanism3. The
most frequently affected organs are lungs (86%) and liver (85%).
Injured cells leak intracellular enzymes like lactate dehydrogenase,
glutamic oxaloacetic transaminase, glutamic pyruvate transaminase.These
enzymes may be used as potential predictors of timing and grade of
hypoxic ischemic injury in both perinatal period and in infants with
antepartum asphyxia. [2, 3, 4, 5]
 This study intends to analyse the occurrence of hypoxic hepatitis
in full-term neonates after perinatal asphyxia and correlation between
rise in enzymes and severity of the asphyxia and CNS symptomatology
and hence, to know whether it can be used as a prognostic tool for
assessment of degree of hypoxic ischemic encephalopathy during first
hours of life and hence the study is undertaken.
REVIEW OF LITERATURE
Karlsson Mathias et al in their study  at Sweden, found that in 12 of
the 26(46.1%)  asphyxiated infants,  serum alanine aminotransferase (S-
ALAT) pattern compatible with hypoxic hepatitis was found. Similar
patterns were seen in serum aspartate aminotransferase (S-ASAT). S-
ALAT and ASAT concentrations 0-72 h after birth correlated significantly
with severity of hypoxic-ischaemic encephalopathy .4
Saili et al in their studyat Kalawati Saran Children's Hospital, New
Delhi, found that two-thirds of the neonates(64.52%) with perinatal
asphyxia had a deranged hepatic function reflected through rise in serum
aminotransferases and alkaline phosphatase. Out of this group with
elevated enzymes 60% expired, and in the other group with normal levels
of enzymes 9.1% expired, the difference was statistically
significant(P<0.01). Alkaline phosphatase was raised in 58% of the
subjects.5
Aylin Tarcanet  al   in  their  study  at Turkey, found that 22 of  the 56
newborns with perinatal asphyxia which was diagnosed based on elevated serum alanine
transaminase level (>100 U/L, twice upper normal). Fetal distress, thrombocytopenia,
convulsions, pathologic findings on imaging of the central nervous system, and a high rate of
intrauterine growth retardation were the factors significantly associated with hepatocyte
injury. This damage was also associated with high mortality .6
Esque  Ruiz  et  al  in  their  study  at  Spain,  found  that  the  newborn  infants  with  HIE
presented higher levels of transaminases, especially of AST (p= 0.000001). No relation was
found between values of blood ammonia and transaminases. 7
Sanath Reddy et al in their study at Postgraduate Institute of
Medical Education and Research, India found that LDH at 72 hours of
life was the most accurate test for discriminating asphyxia from other
illnesses among neonates who presented with non-specific signs of
illness. LDH could be used at 3 days of age to diagnose asphyxia
retrospectively in such cases. Raised LDH had 100% sensitivity, while
CK-MB had 100% specificity for asphyxia .8
Lackmann et al in their study at University of Marburg, found that
theasphyxiated newborns had significantly increased serum activities of
lactate dehydrogenase and hydroxybutyrate dehydrogenase  up to 72 h
postpartum, whereas healthy newborns showed higher creatine kinase
and lactate dehydrogenase activities. Only the activities of glutamic
pyruvate transaminase, lactate dehydrogenase, and hydroxybutyrate
dehydrogenase seemed to depend on the oxygen supply of the fetus or
newborn.If other causes of increased serum enzyme activities are
excluded, elevated serum activities should draw one's attention to a
perinatal hypoxic-ischaemic insult of the newborn. 9
Dhanjal  GS,  Kaur  N,  Kaur  H.  Study  of  Liver  Function  Test  in
Perinatal Asphyxia at a Tertiary Care Center in Haryana. Int Arch
BioMed Clin Res. 2016;2(4):26-28.DOI: 10.21276/iabcr.2016.2.4.6states
that the mean ±SD value of serum ALT and AST in cases was 100.17 ±
35.50 IU/L and 84.13 ± 44.49IU/L respectively, while in the control
group serum ALT and AST were 30.25± 9.49 IU/L and 41.97 ±11.49
IU/L respectively, the differences were statistically significant (p < 0.001)
and that elevations are significant in asphyxiated newborns.
SHAH.P  et  al[49]. in their study among 244 neonates studied
showed that hepatic dysfunction has been documented in 85% of the
neonates as characterised by aspartate aminotransferase >100 IU/l or
alanine  aminotransferase  >  100  IU/l  at  any  time  during  the  first  week
after birth.
SV  GODAMBE  et  al.  noted  thatmean  SGPT  levels  in  this  study
were noted to increase from 35.3 ± 28.8 IU/L in mild asphyxia to 65.6 ±
33.2 IU/L in severe asphyxia and that it correlated well with the
histological changes in the liver biopsy of the neonates undergoing
asphyxia.
MD. TARIQUL ISLAM ET AL. Alteration of Hepatic Function:
Helpful to Diagnose and AssessSeverity of Perinatal Asphyxia
BANGLADESH J CHILD HEALTH 2010; VOL 34 (1): 7-10[54]states
that The mean AST, ALT, ALP, STP, S. albumin and TSB of asphyxiated
babieswere 76.3±37.4 U/L, 82.2±48.08 U/L, 369.6±123.05 U/L, 55.7±8.8
U/L, 32.6±5.5 g/L& 5.5±2.01mg/dL respectively and those of normal
babies were 23.5±8.5 U/L, 26.5±7.8U/L, 208.2±46.9 U/L, 66.3±10.4 g/L,
40.9±6.5 g/L and 4.5±1.2 mg/dl respectively andthese differences were
statistically significant (P <0.001). On the other hand nosignificant
changes  were  noted  in  prothrombin  time.  The  rise  of  AST,  ALT,  ALP
andPT also showed a significant positive correlation with the severity of
asphyxia and thestages of HIE.
And thus It was concluded that estimation of hepatic enzymes can
be used to diagnose perinatal asphyxia and also to assess its severity.
OBJECTIVES OF THE STUDY
? To know the occurrence of hypoxic hepatitis in full-term neonates
after birth asphyxia by comparing the cord blood levels of liver
enzymes
? To know whether the degree of hypoxic hepatitis correlates with
the severity of the asphyxia and CNS symptomatology.
? To assess whether elevated enzyme levels can be used a prognostic
indicator for assessment of degree of hypoxic ischemic
encephalopathy during first few hours of life.
MATERIALS AND METHODS
Study Design : Case control Study
Study place : Kilpauk medical college and
Hospital
Study period : From March 2017 to August 2017
Study population : Term newborns admitted in the
Newborn Intensive Care Unit of
Kilpauk medical college and
hospital with History of birth
asphyxia
Sample size :          130 term newborns
Study approval : Ethics committee Kilpauk medical
College And hospital
Sample Size Calculation
Sample size was determined based on Study
Hepatic Dysfunction in Asphyxiated Neonates: Prospective Case-
Controlled Study
Authored by :Mukesh Choudhary et al
Published in :Clin Med Insights Pediatr. 2015; 9: 1–6.
In this study, the prevalence of liver function impairment was seen in
42.85% of asphyxiated neonates.
Description
The confidence level is estimated at 95% with a z value of 1.96
The confidence interval or margin of error is estimated at +/-9
Assuming P % =42.85 and q%=57.15
n = p% x q% x [z/e%] ²n= 42.85 x 57.15 x [1.96/9]²
n= 116.14 (rounded to 116)
With Attrition 10% = 116+12=128 (rounded to 130) Therefore 130 is the
minimum sample size required for the study assuming 80% as the power
of study. In my study I plan to recruit a minimum of 130 subjects. 65
Cases and 65 Controls.
Inclusion criteria
1. Gestational age ? 37 weeks.
2. Birth weight Appropriate for gestational age.
3. The neonates will be identified to have experienced perinatal
asphyxia when at least 2 of the following are present:[12]
a. Intrapartum signs of fetal distress, as indicated by late
decelerations on fetal monitoring or by thick meconium
staining of the amniotic fluid.
b. Apgar score of <6 at one minute of life.
c. Resuscitation with >1 minute of positive pressure
ventilation before stable spontaneous respiration.
Exclusion criteria
1) Major Congenital malformations.
2) Maternal drug addiction.
3) Neonates born to mothers who would have received magnesium
sulphate within 4 hours prior to delivery or opiods
(pharmacological depression)
4) Preterm neonates
The control group
It will include 65 full term apparently healthy neonates appropriate
for gestational age without signs of perinatal asphyxia as evidenced by
normal fetal heart rate patterns, clear liquor and five minute Apgar score
?6[12]
METHOD OF DATA COLLECTION
All neonates included in the study will have the following done:
1. Detailed maternal history, assessment of intrauterine fetalwell being
by non-stress test, birth events, Apgar score, sex of the baby and
weight of the baby. Gestational age will be assessed by New Ballard
scoring system.
2. Thorough clinical and neurological examination will be done.
Assessment of severity of HIE, as defined by Sarnat&Sarnat, 1976.
3. Cord Blood sample will be collected from the neonates and will be
sent for:
a) alanine transaminase, aspartate transaminase levels
     b) Lactate Dehydrogenase (LDH) levels and analysed by enzymatic
method at the laboratory, Dept of Biochemistry, Kilpauk Medical
College and Hospital, Chennai.
4.  Peripheral venous samples repeated after 24 hours of admission
are compared for the elevation in the enzymes in asphyxiated vs
non asphyxiated neonates.
Statistical methods
Presence or absence of Asphyxia was considered as primary
outcome variable.  Cord Blood and serum Liver function parameters at 24
hours after delivery were considered as primary explanatory variables.
HIE stage was consider as other explanatory variable, other neonatal
parameters were considered as other explanatory variables.
Descriptive analysis
Descriptive analysis was carried out by mean and standard
deviation for quantitative variables, frequency and proportion for
categorical variables. Data was also represented using appropriate
diagrams like bar diagram, pie diagram and box plots.
Various demographic and obstetric parameters were considered as
Neonatal explanatory variables.
Inferential statistics
Both the study groups (Asphyxia and No Asphyxia) were
compared with respect to the HIE-stage, obstetric parameters, etc. The
association between categorical explanatory variables and quantitative
outcome was assessed by comparing the mean values. The mean
differences along with their 95% CI were presented. Independent sample
t-test/ ANOVA was used to assess statistical significance. Association
between quantitative explanatory and outcome variables was assessed by
calculating person correlation coefficient and the data was represented in
a scatter diagram.
The association between explanatory variables and categorical
outcomes was assessed by cross tabulation and comparison of
percentages. Chi square test was used to test statistical significance.
P value < 0.05 was considered statistically significant.  IBM SPSS
version 22 was used for statistical analysis.[56]
RESULTS
Table 1
Descriptive analysis of Study group in study population (N=130)
Study group Frequency Percentage
Asphyxia 65 50.00%
No Asphyxia 65 50.00%
Among the study population, 65(50%) people were in Asphyxia
group and 65(50%) people had no asphyxia. ( table 1& Figure 1)
Figure 1
Bar chart of study group distribution in study population (N=130)
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Table 2
Comparison of Demographic in study population (N=130)
Gender
Study group
Chi
square
P-
valueAsphyxia(N=65) NoAsphyxia(N=65)
Male 43 (66.15%) 32 (49.23%)
3.813a 0.051
Female 22 (33.85%) 33 (50.77%)
Among children with asphyxia, 43(66.15%) were boys and
22(33.85%) were girls. The number of Male and Female was 32(49.23%)
and 33(50.77%) respectively in control group. The differences gender
proportion between the two groups was statistically not significant (P
value 0.051).( table 2 & figure 2)
Figure 2
Bar chart of comparing gender composition of the two study groups
(N=130)
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Table 3Comparison of Obstetric parameter of study population
(N=130)
Obstetric
parameter
Study group
Chi
square P-valueAsphyxia
(N=65)
No
Asphyxia
(N=65)
Gravida
1 47 (72.31%) 42 (64.62%)
* *
2 12 (18.46%) 22 (33.85%)
3 4 (6.15%) 1 (1.54%)
4 2 (3.08%) 0 (0%)
Para
0 47 (72.31%) 42 (64.62%)
* *1 16 (24.62%) 23 (35.38%)
2 2 (3.08%) 0 (0%)
Live Birth
0 48 (73.85%) 42 (64.62%)
* *1 15 (23.08%) 23 (35.38%)
2 2 (3.08%) 0 (0%)
Abortion
0 61 (93.85%) 64 (98.46%)
1.872a 0.171
1 4 (6.15%) 1 (1.54%)
*No statistical test was applied considering “0” subjects in one of the
cells
Among the children with asphyxia 47 (72.31%) were gravida-
1subjects.The proportion gravida-2, 3 and 4 was 42 (64.62%), 4 (6.15%)
and   2 (3.08%) respectively.  The number of gravida 1, 2 and 3 was 42
(64.62%), 22 (33.85%) and 1 (1.54%) in control group.( table 3 & figure
3).
Among the children with asphyxia group was 47 (72.31%)were
Para-0 subjects, 16 (24.62%) were para-1 subjects and   2 (3.08%) were
para-2 subjects.  The number of Para 0 and 1 was 42 (64.62%) and 23
(35.38%) in control group. (table 3 &figure  4).
Among the children with asphyxia group   was 48 (73.85%) were
Live birth-0 subjects,   15 (23.08%) were Live birth-1 subjects and 2
(3.08%) were Live birth-2 subjects. The number of Live birth 0 and 1 was
42 (64.62%) and23 (35.38%) in control group.( table 3 & figure 5).
Among the children with asphyxia group was 61 (93.85%) were
Abortion-0 and 4 (6.15%) were Abortion-1 subjects. The number of
abortion 0 and 1 was 64 (98.46%) and 1(1.54%) in control group. The
difference abortion proportion between the two groups was statistically
not significant (P value 0.171). (table 4 & figure 6).
Table 22
 Association of Study group with Mode of Delivery of study
population (N=130)
Mode of
Delivery
Study group
Chi
square
P-
valueAsphyxia(N=65) NoAsphyxia(N=65)
FORCEPS 4 (6.15%) 3 (4.62%)
0.570a 0.752
LSCS 36 (55.38%) 33 (50.77%)
NVD 25 (38.46%) 29 (44.62%)
Among the Children with asphyxia was 4 (6.15%) were in forceps
delivery. The number LSCS and NVD was 36 (55.38%) and 25 (38.46%)
respectively.The number of Mode of delivery in Forceps, LSCS and NVD
was 3 (4.62%), 33 (50.77%) and 29 (44.62%) in controls group. The
difference Mode of delivery between the two groups was statistically not
significant (P value 0.752). ( table 22& figure 25)
Figure 25
Bar chart of Mode of delivery betweentwo groups (N=130)
Table 4
Descriptive analysis of Mode of Delivery in study population (N=130)
Mode of Delivery Frequency Percentages
LSCS 69 53.08%
NVD 54 41.54%
FORCEPS 7 5.38%
Among  the  study  population,  the  Mode  of  delivery  was  LSCS  in
53.08% of the cases. The proportion of women delivered by NVD and
forceps was 41.54% and 5.38% respectively. (table 4 & figure 7)
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Table 5
Comparison of mean Weight and length between study groups
(N=130)
Parameter
Mean ±SD
P valueAsphyxia
(N=65)
No Asphyxia
(N=65)
I. weight 2.97 ± 0.45 3.08 ± 0.43 0.198
II. Length 52.27 ± 1.78 50.94 ± 2.32 <0.001
The mean weight of children with asphyxia was 2.97± 0.45 and in
No Asphyxia group it was  3.08± 0.43.  The between  two  groups  in
their weight was statistically not significant. (P value 0.198). The mean
length of children with asphyxia was 52.27 ± 1.78 and in No asphyxia
group it was 50.94 ± 2.32. The between two groups in their length was
statistically significant. (P value <0.001). ( table 5 & figure 8)
Figure 8
Bar chart of study group between weight & Length distribution in
study population (N=130)
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Table 6
Association of Study group with RD of study population (N=130)
RD
Study group
Asphyxia (N=65) No Asphyxia (N=65)
0 36 (55.38%) 65 (100%)
1 29 (44.62%) 0 (0%)
*No statistical test was applied considering “0” subjects in one of the
cells.
Among the children with asphyxia was 36 (55.38%)were not
having RD, and 29 (44.62%) were having RD. So in our study the
majority of the subjects not had respiratory distress.
Figure 9
Bar chart of study group between rd distribution in study population
(N=130)
Table 7
Comparison of mean of   Liver Function parameters   between study
groups (N=130)
Liver
Function
parameters
Study group
P-valueAsphyxia
(N=65)
No Asphyxia
(N=65)
Cord Blood
I. ALT1 54.26 ± 15.11 29.69 ± 10.64 <0.001
II. AST1 131.22 ± 32.66 58.71 ± 20.2 <0.001
III. LDH1 530.34 ± 82.16 362.62 ± 131.76 <0.001
After 24 hours
I. ALT2 108.98 ± 39.39 40.95 ± 9.97 <0.001
II. AST2 191.26 ± 72.44 74.49 ± 20.64 <0.001
III. LDH2 895.83 ± 252.19 404.8 ± 118.33 <0.001
Rate of Elevation (per day)
I. Elevation
ALT1 54.72 ± 35.46 11.26 ± 8.43 <0.001
II. Elevation
AST1 60.05 ± 65.46 15.78 ± 12.42 <0.001
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III. Elevation
LDH1 365.49 ± 231.04 42.18 ± 78.26 <0.001
The mean Cord Blood ALT in children with asphyxia was 54.26±
15.11 and in No asphyxia group it was 29.69± 10.64, the difference in
cord blood ALT between the two groups was statistically significant
(p value <0.001). (table 7 & figure 10).
The mean Cord Blood AST in children with  asphyxia was 131.22±
32.66and in  No asphyxia group it was 58.71± 20.2 , the difference in
cord blood AST between the  two groups  was  statistically  significant
(p value <0.001). (table 7 & figure 11).
The mean Cord Blood LDH in  children with asphyxia was
530.34± 82.16 and in  No asphyxia group it was 362.62± 131.76, the
difference in cord blood LDH between the two groups was
statistically significant (p value <0.001). ( table 7 & figure 12).
The mean after 24 hours ALT in children with  asphyxia was
108.98± 39.39 and in No asphyxia group  it was 40.95± 9.97, the
difference after 24 hours ALT between the two groups was
statistically significant (p value <0.001). (Table 7 & figure 13).
 The mean after 24 hours AST in children with  asphyxia was
191.26± 72.44 and  No asphyxia  group it was 74.49± 20.64, the
difference after 24 hours AST between the two groups was
statistically significant (p value <0.001). (table 7 & figure 14).
 The  mean  after  24  hours  LDH  in   children  with  asphyxia  was
895.83± 252.19 and  No asphyxia group it  was 404.8± 118.33, the
difference after 24 hours LDH between the two groups was
statistically significant (p value <0.001). (table 7 & figure 15).
The  mean  Rate  of  Elevation  (per  day)  ALT  in  children  with
asphyxia was 54.72± 35.4 and No asphyxia group it was 11.26± 8.43, the
difference Rate of Elevation (per day) ALT between the two groups was
statistically significant (p value <0.001). (Table 7 & figure 16).
The  mean  Rate  of  Elevation  (per  day)  AST  in  children  with
Asphyxia was 60.25± 65.46 and No asphyxia group it was 15.78± 12.42,
the difference Rate of Elevation (per day) AST between the two groups
was statistically significant (p value <0.001). (table 7 & figure 17).
The  mean  Rate  of  Elevation  (per  day)  LDH  in  children  with
asphyxia was 365.49± 231.04  and  No asphyxia group it was 42.18±
78.26, the difference Rate of Elevation (per day) LDH between the two
groups was statistically significant (p value <0.001). (table 7 & figure 18)
Figure 10
Bar chart of study group between Cord Blood distribution in study
population (N=130)
Figure 11
Bar chart of study group between After 24 hours distribution in
study population (N=130)
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Bar chart of study group between Rate of Elevation (per day)
distribution in study population (N=130)
Table 8
Association of Study group with HIE-STAGE of study population
(N=130)
HIE-
STAGE
Study group
Asphyxia(N=65) NoAsphyxia(N=65)
1 21 (32.31%) 0 (0%)
2 40 (61.54%) 0 (0%)
3 4 (6.15%) 0 (0%)
*No statistical test was applied considering “0” subjects in one of the
cells
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Among the Children with asphyxia was 21 (32.31%) were HIE-
stage -1 subjects. The number of HIE stage 2 and 3 was 40 (61.54%) and
4 (6.15%) respectively. The number of HIE-stage 0 was 65(100%) in
controls group.( table 8 & figure 13)
Figure 13
Bar chart of study group between HIE-stagedistribution in study
population (N=130)
Table 9
Association of Study group with MSL of study population (N=63)
MSL Study group
Asphyxia(N=63) NoAsphyxia
Clear liquour 49 (77.78%) 0 (0%)
Meconium
stained
14 (22.22%) 0 (0%)
*No statistical test was applied considering “0” subjects in one of the
cells
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Among the Children with asphyxia was 49 (77.78%) were non
meconium stained liquour subjects and 14 (22.22%) were Meconium
stained liquoursubjects in the study population.  (Table 9)
Table 10
Association of seizures with HIE-STAGE of study population
(N=130)
HIE-
STAGE
Seizures
absent present
0 65 (100%) 0 (0%)
1 16 (76.19%) 5 (23.81%)
2 23 (57.5%) 17 (42.5%)
3 2 (50%) 2 (50%)
*No statistical test was applied considering “0” subjects in one of the
cells.
Among the study population, the HIE-stage 0, 65(100%) were
having no seizures subjects. The number of HIE-stage 1,2and 3 was 16
(76.19%), 23 (57.5%) and 2 (50%) respectively. In the HIE stage 1, 2 and
3 was 5 (23.81%), 17 (42.5%) and 2 (50%) were having seizure
subjects.(table 10 & figure 14)
Figure 14
 Bar chart of seizures between HIE-stage distribution in study
population (N=130)
Table11
Comparison of mean Cord Blood ALT1 across study groups (N=130)
(I) HIE-
STAGE
Mean ± Std.
Dev
Mean
differe
nce
95% Confidence
Interval for Mean
P value
Lower
Bound
Upper
Bound
0 29.69 ± 10.64
1 50.43 ± 7.12 -20.736 -27.15 -14.32 <0.001
2 55.15 ± 17.41 -25.458 -30.59 -20.32 <0.001
3 65.5 ± 17.69 -35.808 -48.98 -22.64 <0.001
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The Mean Cord Blood ALT with in the HIE-stage 0 was 29.69±
10.64, HIE-stage 1, 2 and 3 was 50.43± 7.12, 55.15± 17.41 and 65.5±
17.69 respectively. The mean difference of Cord blood ALT -20.74,-
25.46 and -35.81 HIE stage was statistically significant (p value <0.001)(
table 11 & figure 15)
Figure 15
Bar chart of  Cord Blood ALT1 across study groups (N=130)
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Table 12
Comparison of mean After 24 hours ALT2 across study groups
(N=130)
(I)
HIESTAG
E
Mean ± Std. Dev Meandifference
95%
Confidence
Interval for
Mean
P value
Lower Bound UpperBound
0 40.95 ± 9.97
1 84.1 ± 34.51 -43.141 -56.15 -30.13 <0.001
2 120.55 ± 36.23 -79.596 -90.01 -69.18 <0.001
3 124 ± 40.89 -83.046 -109.74 -56.35 <0.001
The Mean after 24 hours ALT with in the HIE-stage 0 was 40.95±
9.97, HIE-stage 1, 2 and 3 was 84.1± 34.51, 120.55± 36.23 and 124±
40.89 respectively. The mean difference of after 24 hours ALT -43.14,-
79.60 and  -83.05 HIE stage was statistically significant (p value <0.001)
(table 12 & figure 16)
Figure 16
Bar chart of After 24 hours ALT2 across study groups (N=130)
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Table 13
Comparison of mean Rate of Elevation (per day) ALT across study
groups (N=130)
(I)
HIESTA
GE
Mean ± Std.
Dev
Mean
differen
ce
95%
Confidence
Interval
for Mean
P value
Lower
Bound Upper Bound
0 11.26 ± 8.43
1 33.67 ± 33.58 -22.405 -34.20 -10.61 <0.001
2 65.4 ± 31.64 -54.138 -63.58 -44.69 <0.001
3 58.5 ± 40.58 -47.238 -71.45 -23.03 <0.001
The Mean Rate of Elevation (per day) ALTwith in the HIE-stage 0
was11.26± 8.43, HIE-stage 1, 2 and 3 was 33.67± 33.58, 65.4± 31.64 and
58.5± 40.58 respectively. The mean difference of after 24 hours ALT -
22.41, -54.14 and -47.24 HIE stage was statistically significant (p value
<0.001) (table 13 & figure 17)
Figure 17
Bar chart of Rate of Elevation (per day) ALT1 across study groups
(N=130)
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Table 14
Comparison of mean Cord Blood AST across study groups (N=130)
(I)
HIESTAG
E
Mean ± Std. Dev Meandifference
95%
Confidence
Interval for
Mean
P value
Lower
Bound
Upper
Bound
0 58.71 ± 20.2
1 134 ± 26.21 -75.292 -88.44 -62.14 <0.001
2 126.25 ± 33.66 -67.542 -78.07 -57.01 <0.001
3 166.25 ± 37.86 -107.542 -134.53 -80.55 <0.001
The Mean Cord Blood AST with in the HIE-stage 0 was 58.71±
20.2, HIE-stage 1, 2 and 3 was 134± 26.21, 126.25± 33.66 and 166.25±
37.86 respectively. The mean difference of Cord blood AST -75.29,-
67.54 and -107.54 HIE stage was statistically significant (p value <0.001)
(table 14 & figure 18)
Figure 18
Bar chart of Cord Blood AST across study groups(N=130)
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Table 15
Comparison of mean After 24 hours AST across study groups
(N=130)
(I)
HIESTAGE Mean ± Std. Dev
Mean
difference
95% Confidence
Interval for Mean P value
Lower Bound UpperBound
0 74.49 ± 20.64
1 190.48 ± 50.56 -115.984 -142.62 -89.35 <0.001
2 190.23 ± 85.28 -115.733 -137.06 -94.41 <0.001
3 205.75 ± 8.62 -131.258 -185.92 -76.60 <0.001
The Mean after 24 hours AST with in the HIE-stage 0 was 74.49±
20.64, HIE-stage 1, 2 and 3 was 190.48± 50.56, 190.23± 85.28 and
205.75± 8.62 respectively. The mean difference of after 24 hours AST -
115.98,-115.73 and  -131.26 HIE stage was statistically significant (p
value <0.001) (table 15 & figure 19)
Figure 19
Bar chart of After 24 hoursAST across study groups (N=130)
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Table 16
 Comparison of mean Rate of Elevation (per day) AST across study
groups (N=130)
(I)
HIESTA
GE
Mean  ±  Std.
Dev
Mean
difference
95%
Confidence
Interval for
Mean
P value
Lower
Bound
Upper
Bound
0 15.78 ± 12.42
1 56.48 ± 44.58 -40.692 -64.17 -17.21 <0.001
2 63.98 ± 76.51 -48.190 -66.99 -29.39 <0.001
3 39.5 ± 34.46 -23.72 -71.90 24.47 0.332
The Mean Rate of Elevation (per day) ASTwith in the HIE-stage 0
was15.78± 12.42, HIE-stage 1, 2 and 3 was 56.48± 44.58, 63.98± 76.51
and 39.5± 34.46 respectively. The mean difference of after 24 hours AST
-40.69,-48.19 and -23.72 HIE stage was statistically significant (p value
<0.001) ( table 16 & figure 20)
Figure 20
Bar chart of Rate of Elevation (per day)  AST across study
groups(N=130)
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Table 17
Comparison of mean Cord Blood LDH across study groups (N=130)
(I)
HIESTAGE
Mean ± Std.
Dev
Mean
difference
95% Confidence
Interval for Mean P value
Lower Bound Upper Bound
0 362.62 ± 131.76
1 527.81 ± 57.53 -165.194 -219.86 -110.52 <0.001
2 537.7 ± 72.96 -175.085 -218.85 -131.31 <0.001
3 470 ± 217.04 -107.38 -219.59 4.82 0.061
The Mean Cord Blood LDH with in the HIE-stage 0 was 362.62±
131.76, HIE-stage 1, 2 and 3 was 527.81± 57.53, 537.7± 72.96 and 470±
217.04 respectively. The mean difference of Cord blood AST -165.19,-
175.09 and -107.38 HIE stage was statistically significant (p value
<0.001)  ( table 17 & figure 21)
Figure 21
Bar chart of Cord Blood LDH across study groups (N=130)
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Table 18
Comparison of mean   After 24 hours LDH across study groups
(N=130)
HIE
STAGE
Mean ± Std. Dev Meandifference
95% Confidence
Interval for
Mean
P value
Lower Bound UpperBound
0 404.8 ± 118.33
1 799.19 ± 218.64 -394.390 -490.03 -298.75 <0.001
2 938.25 ± 232.45 -533.450 -610.02 -456.88 <0.001
3 979 ± 486.91 -574.200 -770.48 -377.92 <0.001
The Mean after 24 hours LDH with in the HIE-stage 0 was 404.8±
118.33, HIE-stage 1, 2 and 3 was 799.19± 218.64, 938.25± 232.45 and
979± 486.91 respectively. The mean difference of after 24 hours AST -
394.39,-533.45 and -574.2 HIE stage was statistically significant (p value
<0.001) (table 18 & figure 22)
Figure 22
 Bar chart of After 24 hours LDH across study groups (N=130)
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Table 19
Comparison of mean Elevation (per day)  LDH across study groups
(N=130)
HIE
STAGE
Mean ± Std. Dev Meandifference
95%
Confidence
Interval for
Mean
P value
Lower Bound UpperBound
0 42.18 ± 78.26
1 271.38 ± 220.44 -229.196 -311.87 -146.52 <0.001
2 400.55 ± 210.65 -358.365 -424.56 -292.17 <0.001
3 509 ± 363.39 -466.815 -636.50 -297.13 <0.001
The Mean Rate of Elevation (per day) LDHwith in the HIE-stage 0
was 42.18± 78.26, HIE-stage 1, 2 and 3 was 271.38± 220.44, 400.55±
210.65 and 509± 363.39respectively. The mean difference of after 24
hours AST -229.196, -358.37 and -466.815 HIE stage was statistically
significant (p value <0.001) ( table 19& figure 23)
Figure 23
Bar chart of Elevation (per day) LDH across study groups (N=130)
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Table 20
Comparison of HIE-STAGE and APGAR 1 minutes among study
group (N=130)
HIE-STAGE Apgar 1 Median (IQR) P-value (Kruskal –Wallis test)
0 7(7 to 7.50)
<0.001
1 4(4 to 5)
2 4( 4 t0 5)
3 2.5( 2 to 3.75)
The   Median of Apgar 1 minutes was 7(IQR 7 to 7.50) were HIE
stage 0 subjects. The number of HIE-stage 1, 2 and 3 was 4(4 to 5), 4(4 t0
5) and 2.5(2 to 3.75) respectively.
The difference HIE-stage proportion Apgar 1minutes was
statistically significant (P value <0.001).( table 20 & figure 24)
Figure 24
Box and whisker plot of Apgar 1 minutes between HIE-stage in study
group (N=130)
Table 21
Comparison of HISTAGE and APGAR 5 minutes among study
group (N=130)
HIESTAGE Apgar 5 Median(IQR)
P-value (Kruskal –
Wallis test)
0
<0.001
1 6( 6 to 6)
2 6( 6 to 6)
3 4.50( 4 to 5)
The    Median  of  Apgar  5  minutes  was  6(IQR  6  to  6)  were  HIE
stage 1 subjects. The number of HIE-stage 2 and 3 was 6(6 to 6) and
4.50(4 to 5) respectively. The difference HIE-stage proportion Apgar
5minutes was statistically significant (P value <0.001).( table 21)
Table 1
Association of Study group with Cord Blood ALT1 category of study
population (N= 130)
Cord Blood ALT1
category
Study group
Chi square P-valueAsphyxia
(N=65)
No
Asphyxia
(N=65)
High(>40) 62 (95.38%) 13 (20%)
75.668a <0.001
Normal(up to 39) 3 (4.62%) 52 (80%)
Among the children with asphyxia group was 62 (95.38%)were in
elevatedcord blood ALT1 category high and 3 (4.62%) were in normal
subjects. The number ofelevated cord blood ALT1 category high and
normal was 13 (20%) and 52 (80%)in control group. The difference cord
blood ALT1 category proportion between the two groups was statistically
significant (P value <0.001). (table 1)
Table 2
Predictive validity of study group as compared toCord BloodALT1
category (N=130)
Parameter Value
95% CI
Lower Upper
Sensitivity 95.4% 90.28% 100.0%
Specificity 80.0% 70.28% 89.7%
False positive rate 20.0% 10.28% 29.7%
False negative rate 4.6% 1.00 % 9.7%
Positive predictive value 82.7% 74.10% 91.2%
Negative predictive value 94.5% 88.54% 100.0%
Diagnostic accuracy 87.7% 82.04% 93.3%
Sensitivity of elevated cord blood ALT1 category (high and
normal) in predicting neonatal asphyxia was 95.4% (95 CI 90.28%_
100%), Specificity of was 80%(95 CI 70.28%_ 89.7%) and the total
diagnostic accuracy was 87.7% (95 CI 82.04%_93.3%) respectively.(
table 2)
Table 3
Association of Study group with Cord Blood AST1 category of study
population (N= 130)
Cord Blood AST1
category
Study group
Chi square P valueAsphyxia
(N=65)
No
Asphyxia
(N=65)
High (>100) 60 (92.31%) 3 (4.62%)
100.064a <0.001Normal(up to 99) 5 (7.69%) 62 (95.38%)
Among the children with asphyxia group was 60 (92.31%)were in
elevated cord blood AST1 category high and 5 (7.69%)were in normal
subjects. The number ofelevated cord blood AST1 category high and
normal was 3 (4.62%)and62 (95.38%) in control group. The difference
cord blood AST1 category proportion between the two groups was
statistically significant (P value <0.001).(table 3)
Table 4
Predictive validity of study group as compared to Cord Blood AST1
category (N=130)
Parameter Value
95% CI
Lower Upper
Sensitivity 92.3% 85.83% 98.8%
Specificity 95.4% 90.28% 100.0%
False positive rate 4.6% 1.00 % 9.7%
False negative rate 7.7% 1.21% 14.2%
Positive predictive value 95.2% 89.98% 100.0%
Negative predictive value 92.5% 86.24% 98.8%
Diagnostic accuracy 93.8% 89.72% 98.0%
Sensitivity of elevated cord blood AST1 category (high and
normal) in predicting neonatal asphyxia was 92.3% (95 CI 85.83%_
98.8%), Specificity of was 95.4% (95 CI 90.28%_ 100%) and the total
diagnostic accuracy was 93.8% (95 CI 89.72%_98%) respectively.(
table 4)
Table 5
Association of Study group with Cord Blood LDH1 category of study
population (N= 130)
Cord Blood LDH1
category
Study group
Chi square P valueAsphyxia
(N=65)
No
Asphyxia
(N=65)
High (>580) 17 (26.15%) 4 (6.15%)
9.598a 0.002
Normal( up to 579) 48 (73.85%) 61 (93.85%)
Among the children with asphyxia group was17 (26.15%)were in
elevated cord blood LDH1 category high and 48 (73.85%)were in normal
subjects. The number ofelevated cord blood LDH1 category high and
normal was4(6.15%) and61 (93.85%)in control group. The difference
cord blood LDH1 category proportion between the two groups was
statistically significant (P value 0.002). (table 5)
Table 6
Predictive validity of study group as compared to Cord Blood LDH 1
category (N=130)
Parameter Value
95% CI
Lower Upper
Sensitivity 26.2% 15.47% 36.8%
Specificity 93.8% 88.00% 99.7%
False positive rate 6.2% 0.31% 12.0%
False negative rate 73.8% 63.16% 84.5%
Positive predictive value 81.0% 64.16% 97.7%
Negative predictive value 56.0% 46.64% 65.3%
Diagnostic accuracy 60.0% 51.58% 68.4%
Sensitivity of elevated cord blood LDH1 category (high and
normal)  in predicting neonatal asphyxia was 26.2% (95 CI 15.47%_
36.8%), Specificity of was 93.8%(95 CI 88%_ 99.7%) and the total
diagnostic accuracy was 60% (95 CI 51.58%_68.4%) respectively.( table
6)
DISCUSSION
In  our  study  65  babies  were  taken  as  cases  and  65  babies  were
taken as controls by simple random sampling. Among the children with
asphyxia, 43(66.15%) were boys and 22(33.85%) were girls. Sex did not
have a statistically significant correlation with asphyxia. However male
babies are more predisposed to asphyxia. This is accordance with
studies of  Gurdeep et.  Al. [55] which also showed a male preponderance.
Similar studies with male babies being more asphyxiated was shown in
studies by Reddy et al (2008) [56] in their study. Another study done by
Paliwalet al (2013) [57] also showed an increased number of males
in both the groups. The cause for the increased incidence of birth
asphyxia in males is not known, neither there is any study regarding the
same.
Among the children with asphyxia 47 (72.31%) were gravida-
1subjects.The proportion gravida-2, 3 and 4 was 42 (64.62%), 4 (6.15%)
and   2 (3.08%) respectively.Among the children with asphyxia group
was 47 (72.31%)were Para-0 subjects, 16 (24.62%) were para-1 subjects
and   2 (3.08%) were para-2 subjectschildren with asphyxia group was 61
(93.85%) were Abortion-0 and 4 (6.15%) were Abortion-1 subjects. In
our study most of the asphyxiated babies belonged to primi mothers and
the order of birth affecting the asphyxia was not statistically significant.
This is also supported by the study of Gurdeep et al. [55] which showed
that parity had no relation with the babies getting asphyxiated. Similar
results were obtained by Reddy et al (2008) [56] and Khreisat et. Al.[58]
Occurrence of meconium staining is significant among the study
population (22.22%) were Meconium stained liquoursubjects. It is
significantly more than the controls. This was also supported by the
studies of 28% of the cases in the study by Gurdeep et. Al [55] and in 8%
of cases in the study done by Reddy et al[56] .
Cesearean section is associated with increased incidence of
perinatal hypoxia (53.08%)than the other modes of delivery. This is also
supported by the study of casey et. Al [61] .
Cord Blood ALT in children with asphyxia was 54.26± 15.11 and
in No asphyxia group it was 29.69± 10.64, the difference in cord blood
ALT  between  the  cases  and  controls  was  statistically  significant  (p
value <0.001). this is also supported by the studies of gurdeep et. Al. [55]
which showed significant elevation in ALT in asphyxiated neonates when
compared to controls.Our results were comparable to those seen by Islam
et al (2010)[59] and Paliwal et al (2013)[57]
The mean Cord Blood AST in children with  asphyxia was 131.22±
32.66 and in  No asphyxia group it was 58.71± 20.2 , the difference in
cord blood AST between the  two groups  was  statistically  significant
(p value <0.001).  similar results were obtained by gurdeep et. Al [55]
Islam et al [59] and Paliwalet al [57]
The mean Cord Blood LDH in  children with asphyxia was
530.34± 82.16 and in  No asphyxia group it was 362.62± 131.76, the
difference in cord blood LDH between the two groups was
statistically significant (p value <0.001).  this  result  is  similar  to  the
studies done by nandachavvi et. Al [60]  which also showed significant
levels of LDH elevation compared to the controls in samples <24 hours.
Mean after 24 hours ALT in children with  asphyxia was 108.98±
39.39 and in No asphyxia group  it was 40.95± 9.97, the difference after
24 hours ALT between the two groups was statistically significant (p
value <0.001)
Mean after 24 hours AST in children with  asphyxia was 191.26±
72.44 and  No asphyxia  group it was 74.49± 20.64, the difference after
24 hours AST between the two groups was statistically significant (p
value <0.001)
Mean after 24 hours LDH in  children with asphyxia was 895.83±
252.19 and  No asphyxia group it  was 404.8± 118.33, the difference
after 24 hours LDH between the two groups was statistically
significant (p value <0.001)this  result  is  similar  to  the  studies  done  by
nandachavvi et. Al [60] gurdeep et. Al. [55] Islam et al (2010)[59] and Paliwal
et al (2013)[57].
The  mean  Rate  of  Elevation  (per  day)  ALT  in  children  with
asphyxia was 54.72± 35.4, (vs 11.26± 8.43 in controls) AST was 60.25±
65.46 (vs 15.78± 12.42 in controls) ,LDH was 365.49± 231.04 (vs.
42.18± 78.26 in controls). The level of enzyme elevation per day also
correlates significantly with the asphyxiated babies than the controls.
Similar results were obtained by nandachavvi et al. [60]
Among the Children with asphyxia was 21 (32.31%) were HIE-
stage -1 subjects. The number of HIE stage 2 and 3 was 40 (61.54%) and
4 (6.15%) respectively. Majority of the cases were from the HIE stage 2.
Number of HIE-stage 1, 2 and 3 was 4(4 to 5), 4(4 t0 5) and 2.5(2
to 3.75) respectively. The difference HIE-stage proportion Apgar
1minutes was statistically significant. Median of Apgar 5 minutes was
6(IQR 6 to 6) were HIE stage 1 subjects. The number of HIE-stage 2 and
3 was 6(6 to 6) and 4.50(4 to 5) Signifying that apgar score at 1 and 5
minutes of life correlates significantly with the HIE staging. This is
also supported by casey et al [61] which showed that 5 minuteapgar is
superior even to umbilical artery cord sampling in determing the neonatal
outcome The sensitivity and specificity of predicting the severity of
asphyxia by the cord blood and liver enzyme elevation at 24 hours of life
are:
Enzyme Sensitivity Specificity
ALT 95.4% 80%
AST 92.3% 95.4%
LDH 26.2% 93.8%
Similar results were obtained by gurdeep et. Al. [55] who showed a
sensitivity of 96% for ALT and 80% for AST.
CONCLUSION
? The liver function tests (ALT and AST) may be helpful in
diagnosing perinatal asphyxia especially in developing nations
where birth details are not available / unreliable.
? Male babies are more predisposed to asphyxia and majority of
them are born to primi mothers via caesarean section.
? Cord blood liver enzymes were significantly elevated in asphyxia
and also the rate of elevation in 24 hour also showed significant
correlation with asphyxia.
? The liver enzymes show a significant co relation with the degree of
asphyxia during the early neonatal period and the sensitivity and
specificity for detecting the same is over 90%.
? They may serve as useful markers for early therapeutic
interventions for perinatal hypoxia.
LIMITATIONS OF THE STUDY
The study was carried out in a relatively smaller sample size and
hence, the power of the study may be lower. Large multicentric trials may
be needed to further prove the efficacy of the liver enzyme profile in
determining the severity and the usefulness of the same in diagnosing and
prognosticating asphyxia.
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PROFORMA
Case no:                                           IP no :
Name:
Age/sex:
Address:
HISTORY:
2. Maternal Medical comorbidities (Dibetes mellitus,
Systemic Hypertension, Anemia)
3. Antenatal CTG abnormalities, if any
4. Birth history : liquour (clear / meconium stained), mode
of delivery, indication
5. If cried immediately after birth, Mode of resuscitation, if
any
6. APGAR
GENERAL EXAMINATION:
Vitals:          HR:                                    RR:
ANTHROPOMETRY:
 Weight:
 Length:
 Head circumference:
HEAD TO FOOT EXAMINATION :
SYSTEMIC EXAMINATION:
CVS: RS:
P/A: CNS:
INVESTIGATION:
Cord blood levels of:
1. Alanine transaminase
2. Aspartate transaminase
3. Lactate Dehydrogenase
Venous blood levels 24 hours later of:
1. Alanine transaminase
2. Aspartate transaminase
3. Lactate Dehydrogenase
IMPRESSION:
SIGNATURE OF STUDENT                                      SIGNATURE OF THE GUIDE
INFORMED CONSENT FORM
STUDY : A COMPARATIVE STUDY OF CORD BLOOD LIVER
ENZYME PROFILES AMONG ASPHYXIATED AND NON-
ASPHYXIATED TERM NEONATES
STUDY CENTRE:  GOVT. KILPAUK MEDICAL COLLEGE HOSPITAL
PATIENT’S NAME:
PATIENT’S AGE:
I.P NO            :
                        Patient may check (         ) these boxes
I confirm that I understood the purpose of the procedure for the above
study. I have the opportunity to ask question and all my questions and
doubts have been answered to my complete satisfaction
I understand that my participation in the study is purely voluntary and that
I am free to withdraw at any time without giving reason, without my legal
rights being affected.
I understand that the Ethics Committeemembers  and the regulatory
authorities will need not my permission to look at my health records, both
in respect of the current study and any further research that may be
conducted in relation to it, even if I withdraw from the study I agree to this
access. However, I understand that my identity will not be revealed in any
information released to third parties or published, unless as required under
the law.
I agree not to restrict the use of any data or results that arise from the
study. I agree to take part in the above study and to comply with the
instructions given during the study and faithfully co operate with the study
team and to immediately inform the study staff if I suffer from any
deterioration in my health or well being or any unexpected or unusual
symptoms.
I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including hematological, biochemical, radiological tests.
Signature / thumb impression:
Patient’s name and address:                                          place:                     date:
Signature of the investigator:
Study investigator’s name:                                             place:                     date:
PARTICIPANTS’ INFORMATION SHEET
Investigator : - Dr.P.M.DEVIPRASADH
Name of the participant : -
TITLE : A COMPARATIVE STUDY OF CORD BLOOD LIVER
ENZYME PROFILES AMONG ASPHYXIATED AND
NON-ASPHYXIATED TERM NEONATES.
You are invited to take part in this research study. We have got approval
from  the  IEC.  You  are  asked  to  participate  because  you  satisfy  the  eligibility
criteria.
What is the purpose of this research?
The Study Is Conducted To Assess Cord Blood Liver Enzyme Profiles
Among Asphyxiated And Non-Asphyxiated Term Neonates
BENEFITS:
This study will help to assess the babies who were more prone for
developing perinatal asphyxia and to minimize readmission and plan for early
discharge.
CONFIDENTIALITY:
           Patients who participated in the study and their details will be maintained
confidentially and at any cost, those details will not be let out.
RIGHT TO WITHDRAW :
Patients   will  not  be  forced  to  complete  the  study.  At  any  cost,  in  such
circumstances the treatment  will not be compromised.
Date  : Signature of the investigator: -
Place  :
Signature/Thumb
impression
of  the participant
ABBREVIATIONS
ALF – Acute liver failure
ALT –  Alanine transaminase
AST  –  aspartate transaminase
LDH –  lactate dehydrogenase
PNH –  perinatal hypoxia
HIE –  hypoxic ischaemic encephalopathy
CP –  Cerebral palsy
SGOT –  serum glutamic oxaloacetic transaminase
SGPT  –  Serum glutamic pyruvate transaminase
MRI –  magnetic resonance imaging
EEG –  electro encephalography


name sex ip mode parity apgar1 apgar5 weight length rd seizures ALT1 ALT2 AST1 AST2 LDH1 LDH2 hie MSL IDM
AYESHA NAWAZ SHERIFF F 17125 LSCS PRIMI 5 6 2.85 52 0 1 59 64 136 213 692 1186 2 0
PREMA VIJAY M 17244 NVD G4P2L2 2 4 2.61 53 1 1 56 66 117 196 592 1632 3 0
PREMA VIJAY (B) M 17245 NVD G4P2L2 3 5 2.2 50 1 1 58 162 196 201 594 832 3 0
RADHIKA PARTHIBAN M 17355 NVD PRIMI 4 6 2.2 52 0 1 52 146 102 196 696 1340 2 0
JEYALAKSHMI VELMURUGAN M 17486 NVD PRIMI 4 6 2.44 48 0 0 56 132 102 146 590 1640 2 1
rekha appu M 17405 LSCS G2P1L1 2 6 2.114 52 0 1 59 126 102 168 586 695 2 1
SUGANYA F 17622 NVD PRIMI 4 6 3.02 50 1 0 56 136 106 146 592 1246 2 0
THILAGA F 17298 LSCS PRIMI 4 5 2.84 52 0 0 49 56 136 198 456 1046 2 0
MEENATCHI NARESH KUMAR F 17449 LSCS G2P1L1 4 5 2.93 51 0 0 56 62 106 132 546 696 1 0 1
ALAMELU DAMODARAN M 17758 LSCS G2P1L1 4 6 3.34 52 0 1 56 146 126 148 594 926 2 0
SAMUNDEESHWARI SHANKAR M 17775 LSCS PRIMI 3 6 2.57 54 0 0 54 156 102 146 592 1023 2 0
PAVITHRA PRABHU M 17808 FORCEPS PRIMI 4 5 3.13 50 1 1 56 136 128 146 596 734 2 0
JALKA PRAVEEN M 17921 FORCEPS PRIMI 3 6 3.114 52 0 1 52 76 102 146 592 796 2 0
AMIRTHAM PARTHASARATHY F 17936 LSCS PRIMI 2 4 3.08 52 0 0 92 136 196 213 146 466 3 0
KALAISELVI RAJESH M LSCS PRIMI 4 7 2.44 52 0 1 56 146 136 201 596 1018 2
MUTHUSELVI M 18059 FORCEPS PRIMI 4 6 3.45 52 1 1 56 146 126 44 596 1246 2 0
SURYA SASIKUMAR M 18138 LSCS PRIMI 4 6 2.13 52 0 0 42 48 144 148 520 640 1 0
SUGANYA SOUNDARRAJAN M 18138 LSCS PRIMI 4 6 3.114 52 0 0 49 62 146 154 486 596 1 1
POONGOTHAI BADRINATH M 18194 LSCS G2P1L1 6 7 3.26 56 0 0 49 62 146 154 540 558 1 1
VENNILA MURUGAN M 18193 LSCS PRIMI 5 6 2.38 56 1 0 56 62 147 196 540 642 1 0
KOWSALYA VIGNESHWARAN F 18283 NVD PRIMI 3 5 2.52 52.3 1 1 57 136 156 640 544 620 2 0
SARANYA RAMALINGAM F 18379 NVD G2P1L1 4 6 3.85 54.4 1 1 56 136 196 213 555 936 2 0
VALLI SHANKAR M 18469 LSCS PRIMI 3 6 2.84 52 1 0 156 197 150 246 556 1094 2 0
KALPANADEVI M 18617 NVD PRIMI 5 6 2.81 56.2 1 1 49 142 146 236 494 696 2 0
KAMALAMMA NAGARAJ M 18747 LSCS G2P1L1 4 5 3.38 54.6 1 1 49 56 144 196 546 623 1 0
PARAMESHWARI VENKATESAN M 18775 LSCS G2P1L1 4 6 2.84 54.3 1 1 49 58 146 196 556 940 1 0
TAMILSELVI SRIDHAR M 18804 LSCS PRIMI 5 6 2.68 52.4 1 1 49 156 154 233 562 946 1 0
SANDHIYA SARAVANAN M 19026 LSCS PRIMI 5 6 2.64 52.4 0 0 56 136 158 213 562 946 2
TAHRA MADHAN M 19049 NVD PRIMI 4 6 3.11 52.1 0 0 49 64 146 182 540 642 1 0
SRILATHA KRISHNAN M 19058 LSCS PRIMI 4 6 2.67 52.3 0 0 44 56 149 158 555 626 1 0
AFRIN FATHIMA ELAVARASI F 19311 NVD G2P1L1 5 6 2.65 57 0 0 54 98 156 210 556 1426 1 0
PRAMILA DHANDAPANI M 19327 LSCS G3P1L1A1 5 6 3.95 52 0 0 58 136 158 196 556 926 1 0
HEMALATHA MURALI F 19428 NVD PRIMI 4 6 2.96 54 0 0 59 64 146 323 596 746 1 0
POORNIMA PARANTHAMAN M 19432 LSCS G3P1L1A1 5 6 3.05 52.1 0 0 56 136 148 213 543 913 1 0
PUSHPALATHA
MANIKKAVENDHAN F 19425 LSCS PRIMI 5 6 2.87 54.2 0 0 56 92 154 213 546 729 1 0
JAYANTHI KUMAR F 19588 LSCS PRIMI 5 7 3.03 52 0 0 49 136 132 210 584 1460 2 0
KANNIGA PARAMESHWARI M 19707 LSCS PRIMI 5 6 3.05 52.4 0 0 48 162 156 170 596 1028 2 0
SONIYA SAKTHIVEL M 19743 LSCS PRIMI 4 6 3.95 52.3 1 1 56 146 196 213 443 859 2 0
KALPANA SARAVANAN M 19768 NVD G3P1L1A1 5 6 3.77 52 1 1 56 136 159 196 458 996 2 0
VANITHALAKSHMI SASIKUMAR F 19946 NVD PRIMI 4 6 2.68 52.3 1 1 55 144 156 213 546 936 2 0
GEETHA CHANDRU M 20266 LSCS PRIMI 4 5 3.14 52.4 0 0 56 132 156 213 548 986 3 1
SULTHAN M 20292 NVD PRIMI 4 5 3.56 53.2 0 0 62 146 148 213 562 946 2 0
FOUZIA KATHAR M 20307 NVD PRIMI 4 6 3.39 54 1 0 56 144 158 213 562 936 2 0
TAMILSELVI SAKTHIVEL F 20643 NVD PRIMI 5 6 2.56 56 0 1 56 94 136 223 547 919 2 0
JANSI RANI M 20653 LSCS PRIMI 4 5 3.86 56 1 0 57 132 157 225 567 967 2 0
REKHA BARANIDHARAN M 20049 NVD PRIMI 4 6 3.76 52.4 1 1 56 126 124 210 596 1024 1 0
NANDHINI RAJESH F 20963 LSCS PRIMI 4 6 3.2 52 0 0 30 50 100 211 350 964 1 0
SRIDEVI SASIKUMAR F 21091 LSCS PRIMI 5 7 3.56 52.4 0 0 44 56 130 186 530 986 2 0
BANULATHA RAKESH M 21118 LSCS PRIMI 5 6 2.51 52.6 0 1 50 83 120 136 526 926 2 0
AJITHA KALAIMANI F 21150 NVD G2P1L1 5 6 2.56 50.4 1 1 56 62 136 284 430 556 1 0
GIRIJA GOVINDHAN M 21155 NVD PRIMI 5 6 2.64 50.9 0 0 56 74 102 135 552 1037 1 0
AMMUKUTTY SAKTHIVEL M 21163 NVD PRIMI 5 7 3.48 50.6 0 0 55 63 120 156 538 729 2 0
PRIYA VIJAYAKUMAR M 21250 FORCEPS PRIMI 5 6 3.03 52.3 1 0 35 42 122 224 536 1011 2 0
RUPAVATHY F 21432 LSCS PRIMI 5 6 2.99 52.4 1 0 55 131 41 107 429 922 2 1
UMA HARIBABU F 21604 NVD G2P1L1 4 6 2.88 50.4 0 1 35 49 94 106 432 936 2 1 1
DURGA VADIVEL F 21661 LSCS G3P1L1A1 3 5 2.52 49.6 0 0 44 131 56 148 402 962 2 1
SURYA KUMAR F 21666 LSCS PRIMI 3 6 3.68 50.4 1 0 44 137 41 129 348 547 2 1
MALAI MURUGAN M 21731 LSCS PRIMI 3 6 2.65 50.4 1 0 42 106 52 108 442 926 1 0
SUNDARAMBAL M 21825 LSCS PRIMI 4 6 3.44 50.6 1 0 56 136 148 248 500 626 2 1
UMA VENKATESAN M 22192 NVD G2P1L1 4 6 2.72 50.6 1 0 57 124 101 140 506 636 2 0
NIRMALA SELVAM F 22201 LSCS G2P1L1 5 7 3.22 52.6 0 0 51 119 107 189 579 726 2 0
PARAMESHWARI VENKATESAN M 22382 NVD PRIMI 5 6 3 50.6 1 0 46 58 116 138 446 720 2 1
JAYANTHI NAGARAJ M 22446 NVD PRIMI 4 7 3.01 50.4 1 0 48 126 110 156 536 632 2 1
SANGEETHA SANKAR M 22590 LSCS PRIMI 5 6 2.83 50.6 0 0 56 114 136 224 446 936 2 1
VANITHA WILSON F 22716 NVD PRIMI 5 6 2.65 50.6 1 0 44 136 110 148 526 627 1 1
priya muthu M 17017 NVD PRIMI 7 8 2.56 50.6 0 0 21 40 36 92 198 229 0
SIVASHANKARI F 17020 NVD G2P1L1 7 8 4 51.1 0 0 19 22 35 65 223 259 0
LAKSHMI SATHISH M 17117 LSCS PRIMI 7 8 3.07 52.4 0 0 34 36 39 68 268 310 0
VASANTHA DHANASEKAR F 17150 LSCS PRIMI 7 8 2.52 50.3 0 0 32 39 37 69 246 288 0
ANJALI MANIKANDAN M 17410 NVD PRIMI 7 8 3.02 50.6 0 0 31 36 42 72 256 310 0
AROKIYA MARY F 17451 LSCS PRIMI 7 8 2.51 52.1 0 0 16 22 46 73 165 193 0
PRIYAPREMRAJ M 17460 LSCS G2P1L1 7 8 2.66 51.9 0 0 19 24 48 65 148 152 0
SIVASANKARI DINESH F 17020 NVD G2P1L1 7 8 4.01 52.4 0 0 29 30 49 79 220 253 0
CHITRA THIRUMANI M 16317 FORCEPS G2P1L1 7 8 3.39 54.7 0 0 25 28 25 85 236 241 0
THILAGA MAHESH F 17298 LSCS PRIMI 7 8 2.84 52.3 0 0 6 29 48 86 296 310 0
SUTHA KRISHNAMOORTHY M 17496 LSCS PRIMI 7 8 3.5 51.9 0 0 11 19 40 49 198 227 0
BULKIS SHANTHI F 17872 LSCS G2P1L1 7 8 2.614 56.2 0 0 15 30 45 43 186 241 0
DHANALAKSHMI VENKATESAN M 17899 LSCS G3P1L1A1 7 8 2.814 49.6 0 0 19 28 49 58 385 501 0
DURGA MURALI F 17898 LSCS PRIMI 7 8 4.2 49.2 0 0 24 36 96 102 460 485 0
JOTHI DURGARAO M 17888 LSCS PRIMI 7 8 2.81 56.7 0 0 31 39 92 94 436 498 0
SUNDARI ARUMUGAM F 17909 LSCS PRIMI 8 8 3.114 53.4 0 0 38 42 56 57 369 497 0
TALKA PRAVEEN M 17922 FORCEPS PRIMI 8 8 3.116 54.2 0 0 25 39 57 62 375 520 0
HEMAVATHY MANNAR F 18007 LSCS PRIMI 8 8 3.24 51.6 0 0 24 46 52 68 450 563 0
GULPASHA BEGAM M 18052 LSCS PRIMI 8 8 2.84 52.3 0 0 21 38 35 39 411 548 0
KANIMOZHI SUDHAKAR F 18064 LSCS G2P1L1 8 8 2.85 50.1 0 0 26 39 62 68 314 594 0
PRIYA JEYANDIRAN M 17337 NVD G2P1L1 8 8 2.82 49.6 0 0 32 40 64 72 198 426 0
RADHA VINAYAGAM F 18094 LSCS G2P1L1 7 8 3.56 52.2 0 0 35 48 52 64 194 410 0
RAVIKUMAR M 18138 LSCS PRIMI 7 8 2.33 49.9 0 0 39 52 51 62 186 358 0
NIRMALA PRABHURAM F 17600 LSCS PRIMI 7 8 2.9 50.6 0 0 37 56 53 65 196 396 0
NANDHINI JAYAKUMAR M 18181 LSCS PRIMI 7 8 3.83 48.6 0 0 41 50 50 72 216 387 0
AMUTHA AIYAPAN F 18188 NVD PRIMI 7 8 3.46 52.1 0 0 40 49 52 63 311 299 0
UMAMAHESHWARI M 18208 NVD G2P1L1 7 8 2.88 50.3 0 0 16 28 42 56 368 329 0
USHA BALAKRISHNAN M 18256 LSCS G2P1L1 7 8 3.386 49.9 0 0 18 56 46 59 450 378 0
BHUVANESHWARI M 18905 LSCS PRIMI 7 8 2.72 51.2 0 0 24 52 85 102 411 458 0
RADHIKA VINOTH M 19042 NVD PRIMI 7 8 2.62 47.3 0 0 28 51 68 94 555 496 0
SUGANYA SENDHIL M 19018 NVD PRIMI 7 8 3.57 52.8 0 0 21 50 60 76 526 586 0
GANGAMMA KUPPAN M 19181 NVD PRIMI 7 8 2.79 49.6 0 0 23 48 50 65 516 520 0
MARYAMMA ANANDASELVAM F 19168 NVD G2P1L1 7 8 3.04 47.4 0 0 20 46 57 69 415 562 0
SANGEETHA JEGAN M 19244 NVD G2P1L1 7 8 3.2 46.3 0 0 22 49 58 72 436 498 0
PUSHPA GULAB F 18802 NVD G2P1L1 7 8 2.67 49.6 0 0 40 44 52 68 620 636 0
MANISHA KANNAN M 19279 NVD PRIMI 7 8 2.69 59.4 0 0 26 29 49 52 624 522 0
MALATHI CHANDRU F 19281 NVD PRIMI 7 8 3.6 48.6 0 0 29 39 49 59 685 697 0
REVATHI SARAVANAN F 19301 LSCS PRIMI 7 8 3.02 52.4 0 0 34 42 65 72 540 486 0
ANU SARANYA F 18934 NVD G2P1L1 8 8 2.66 50.6 0 0 33 45 63 68 224 322 0
KAMATCHI ANBUSELVAM F 18741 LSCS PRIMI 8 8 3.55 49.5 0 0 45 49 67 76 480 489 0
kalaimathi sampath M 19423 LSCS PRIMI 8 8 2.66 48.6 0 0 48 47 69 79 462 485 0
SHANKARI DHARMAPRAKASH F 19424 NVD PRIMI 8 8 2.81 48.4 0 0 42 44 100 108 420 426 0
PREMALATHA MARIYAPPAN M 18622 LSCS PRIMI 8 8 2.75 48.2 0 0 49 59 102 111 411 450 0
RAJESHWARI VENKATESH F 19078 LSCS G2P1L1 8 8 2.89 45.9 0 0 50 54 52 94 416 425 0
HEMAPRABHU F 19294 NVD G2P1L1 8 8 2.98 50.1 0 0 48 52 59 96 316 320 0
BANUPRIYA F 19490 NVD G2P1L1 8 8 4 50.3 0 0 46 56 39 56 328 333 0
KALPANA BALAJI M 19605 NVD PRIMI 8 8 3.14 51.2 0 0 32 39 38 57 342 356 0
SUGANTHI F 19333 FORCEPS PRIMI 7 8 3.18 50.5 0 0 36 44 45 59 359 422 0
SUGANYA VINOTHKUMAR M 19331 NVD PRIMI 7 8 2.6 50.7 0 0 31 49 49 67 411 436 0
GOMATHI NAGARAJ F 19612 LSCS G2P1L1 7 8 3.14 52.6 0 0 34 37 54 64 298 321 0
DEVIHARIPRASADH M 19773 LSCS G2P1L1 7 8 2.77 54.8 0 0 30 35 57 69 285 300 0
VIMALA KRISHNAN M 19303 NVD PRIMI 7 8 3.48 51.2 0 0 28 44 62 75 311 329 0
VINOTHINI PRADHEEP M 19641 LSCS PRIMI 7 8 3.48 50.6 0 0 29 49 65 73 352 400 0
ANJALI MOHAN M 19201 NVD PRIMI 7 8 3.01 50.7 0 0 25 50 68 79 368 376 0
JEYANTHI SURESHKUMAR M 19868 LSCS PRIMI 7 8 2.83 47.6 0 0 27 28 62 69 396 422 0
BHAVANI EZHILARASI M 19448 LSCS G2P1L1 7 8 3.65 49.8 0 0 29 36 59 78 452 468 0
ANITHA SILAMBARASAN F 19954 LSCS G2P1L1 7 8 3.91 50.8 0 0 18 32 57 63 425 495 0
VIMALA RAMESH F 24397 NVD PRIMI 7 8 2.92 52.1 0 0 13 31 120 129 466 498 0
MERLINA SATHISH M 25055 NVD G2P1L1 7 8 3.06 51.6 0 0 26 29 92 108 465 500 0
PREMAKUMARI DHARMA F 25673 LSCS PRIMI 7 8 2.61 50.9 0 0 27 35 94 110 542 489 0
SARASWATHI SHANMUGAM F 25063 LSCS PRIMI 7 8 2.7 53.2 0 0 24 39 93 128 554 446 0
DHATCHAYANI F 24477 NVD PRIMI 8 8 3.3 49.9 0 0 20 28 95 119 594 428 0
tamilselvi F 20713 nvd PRIMI 7 8 3.15 50.2 0 0 45 49 98 99 200 256 0
SARASWATI F 20922 NVD PRIMI 7 8 2.78 49.6 0 0 48 52 28 33 196 211 0
NAGESHWARI F 20974 NVD PRIMI 7 8 3.11 50.3 0 0 56 59 37 39 210 246 0
